FDA Inspection 1250107 — Naimatullah Khan, M.D.`
The FDA completed an inspection of Naimatullah Khan, M.D.` on Aug 30, 2024 in Manchester. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 30, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Manchester (United Kingdom)
Additional Details
Clinical BA/BE